Skip to main content
Journal cover image

Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.

Publication ,  Journal Article
Mielniczuk, LM; Pfeffer, MA; Lewis, EF; Blazing, MA; de Lemos, JA; Shui, A; Mohanavelu, S; Califf, RM; Braunwald, E
Published in: Am Heart J
April 2008

UNLABELLED: Both renal dysfunction and elevated levels of high-sensitivity C-reactive protein (CRP) are associated with a higher risk of cardiovascular (CV) outcomes. However, it remains to be established whether the prognostic value of impaired estimated glomerular filtration rate (GFR) remains after accounting for markers of inflammation. METHODS AND RESULTS: Glomerular filtration rate was estimated using the Modification of Diet in Renal Disease equation in 4178 patients with non-ST or ST-elevation acute coronary syndromes, participating in the A to Z trial. The mean estimated GFR was 68 mL/min, with a median baseline CRP of 20.2 mg/L. Both an estimated GFR <60 mL/min (HR 2.13, 95% CI 1.7-2.6) and a CRP in the fourth quartile (HR 1.7, 95% CI 1.4-2.2) were strong univariate predictors of a CV event (composite of CV death, recurrent myocardial infarction, heart failure, or stroke). After adjusting for baseline CRP, GFR <60 mL/min remained a strong multivariate predictor for CV death (HR 1.82, 95% CI 1.1-2.97). Randomization to high-dose statin therapy was associated with a reduction in the CV composite (adjusted HR 0.69, 95% CI 0.5-0.95) irrespective of baseline renal function. CONCLUSIONS: In a population of patients without overt renal disease, moderate reductions in estimated GFR remain an important prognostic marker. This increased CV hazard associated with an estimated GFR <60 mL/min is independent and additive to markers of inflammation.

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

April 2008

Volume

155

Issue

4

Start / End Page

725 / 731

Location

United States

Related Subject Headings

  • Recurrence
  • Prognosis
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Kaplan-Meier Estimate
  • Inflammation
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Glomerular Filtration Rate
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mielniczuk, L. M., Pfeffer, M. A., Lewis, E. F., Blazing, M. A., de Lemos, J. A., Shui, A., … Braunwald, E. (2008). Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J, 155(4), 725–731. https://doi.org/10.1016/j.ahj.2007.11.031
Mielniczuk, Lisa M., Marc A. Pfeffer, Eldrin F. Lewis, Michael A. Blazing, James A. de Lemos, Amy Shui, Satish Mohanavelu, Robert M. Califf, and Eugene Braunwald. “Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.Am Heart J 155, no. 4 (April 2008): 725–31. https://doi.org/10.1016/j.ahj.2007.11.031.
Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J. 2008 Apr;155(4):725–31.
Mielniczuk, Lisa M., et al. “Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.Am Heart J, vol. 155, no. 4, Apr. 2008, pp. 725–31. Pubmed, doi:10.1016/j.ahj.2007.11.031.
Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, Mohanavelu S, Califf RM, Braunwald E. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J. 2008 Apr;155(4):725–731.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

April 2008

Volume

155

Issue

4

Start / End Page

725 / 731

Location

United States

Related Subject Headings

  • Recurrence
  • Prognosis
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Kaplan-Meier Estimate
  • Inflammation
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Glomerular Filtration Rate